Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +2.00p +0.31% 656.00p 654.00p 656.00p 664.00p 658.00p 658.00p 54,872 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -2.5 -6.9 - 251.00

International Biotechnol... Share Discussion Threads

Showing 426 to 449 of 500 messages
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
14/1/2016
21:36
BLOODY HELL!!!
rathlindri
16/12/2015
21:06
Good move today and with IBB up a further 2.25% today, hopefully more to come tomorrow.
gargleblaster
19/11/2015
13:21
Nice recovery since recent lows in late September, the sector seems quite resilient
rathlindri
05/11/2015
07:43
What a great annual financial report. Should have been headed "Investment made Easy"
philo124
24/10/2015
07:53
In sipp. Day follows night.
philo124
23/10/2015
21:59
Should kick up on Monday given that the IBB was up 3.3% at the close - and IBT is now on a 10% discount!
gargleblaster
29/9/2015
09:43
High teens discount is excessive ......for now
steeplejack
25/9/2015
21:58
Big biotech sell off in the US today - looks like a good buying oppo!!
gargleblaster
08/8/2015
08:51
Any views on BB Biotech (epic Bion) the Swiss based biotech trust? It pays a 5% divi as well as offering the biotech growth story.
tonsil
29/7/2015
08:26
They're being a bit sleepy this morning.Both Gilead and Amgen leapt on Wall St yesterday.
steeplejack
29/7/2015
07:59
Good figures from Gilead announced yesterday after hours saw shares rise around 2.6% in after hours trading.Gilead represents some 8% of IBTs net asset value.
steeplejack
20/7/2015
14:29
Flying here again today, agree current discount seems very overdone
rathlindri
17/7/2015
21:48
Ibt view expressed at AGM is that there should be a 5% discount to allow for unquoted holdings.
peter27
17/7/2015
21:12
I don't plan on selling this until it trades at a premium to NAV which it should do eventually!
gargleblaster
17/7/2015
14:24
Agreed. IBT moved away from this and followed BIOG's strategy. Was buying this when discount was 25%- broker didn't believe it then.
philo124
17/7/2015
14:09
I'm not quite sure why the Woodford Patient Capital Trust is at a premium to asset value of some 12% and IBT is at a 10 % discount.You can rationalise it by recognising that Woodford's trust gives exposure to unlisted biotechs perhaps but nonetheless,the disparity is marked.
steeplejack
16/7/2015
19:55
IBT BIOG IBB and WWH. Hold all, very pleased, not going to stop over time. My only regret was taking profits along the way instead of ballsing it out. Still have a very good exposure to the sector.
philo124
16/7/2015
08:40
A nice run here and in the sector generally
rathlindri
13/4/2015
10:17
Amazing that still at approx 8% discount to NAV!!
gargleblaster
13/4/2015
08:20
Bouncing back?
rathlindri
22/3/2015
07:57
Yep. Good sector not subject to deflationary pressures and very exciting future discoveries.
philo124
21/3/2015
20:48
Took a small holding here on friday morning, hopefully not too late! Have done well with the Axa Framlington Biogen unit trust fund over the last 12 months and I see quite an overlap in share holdings here....best of luck to us all
rathlindri
06/3/2015
01:22
Amazing - I think the last little uplift is because 3% of the IBT portfolio was invested in Pharmacyclics which has just been taken-over by Abbvie. Although the takeout was not at a massive premium to the share price it puts a huge future premium on the value of its Imbruvica drug. RBC Capital analyst Michael Yee said AbbVie is paying seven times the projected Imbruvica peak sales of $6bn – more than any recent takeover of a biotech firm. He explained: “There is scarcity value for drugs that ‘move the needle’ and those command a premium.” Things are getting even hotter in the biotech space!
gargleblaster
06/3/2015
00:37
Outstanding; 150% gain in 12 months!
philo124
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
Your Recent History
LSE
IBT
Internatio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190717 04:32:25